| NR2E3 |
Q9Y5X4
|
nuclear receptor subfamily 2 group E member 3
|
Nuclear receptor
|
|
0.603 |
0.500 |
| JRK |
O75564
|
Jrk helix-turn-helix protein
|
|
|
0.612 |
0.500 |
| MIR3936HG |
|
MIR3936 host gene
|
|
|
0.861 |
0.269 |
| BDNF-AS |
|
BDNF antisense RNA
|
|
|
0.638 |
0.538 |
| TEX41 |
|
testis expressed 41
|
|
|
0.743 |
0.269 |
| ADAMTS9-AS2 |
|
ADAMTS9 antisense RNA 2
|
|
|
0.656 |
0.462 |
| LINC01478 |
|
long intergenic non-protein coding RNA 1478
|
|
|
1.000 |
0.077 |
| LINC01505 |
|
long intergenic non-protein coding RNA 1505
|
|
|
0.821 |
0.192 |
| EHMT2-AS1 |
|
EHMT2 and SLC44A4 antisense RNA 1
|
|
|
0.780 |
0.462 |
| LINC01524 |
|
long intergenic non-protein coding RNA 1524
|
|
|
0.839 |
0.192 |
| C8orf37-AS1 |
|
C8orf37 antisense RNA 1
|
|
|
0.821 |
0.154 |
| STX18-AS1 |
|
STX18 antisense RNA 1 (head to head)
|
|
|
0.890 |
0.154 |
| TRAF3IP2-AS1 |
|
TRAF3IP2 antisense RNA 1
|
|
|
0.792 |
0.154 |
| RAB4B-EGLN2 |
|
RAB4B-EGLN2 readthrough (NMD candidate)
|
|
|
0.641 |
0.654 |
| MIR99AHG |
|
mir-99a-let-7c cluster host gene
|
|
|
0.780 |
0.192 |
| HULC |
|
hepatocellular carcinoma up-regulated long non-coding RNA
|
|
|
0.606 |
0.538 |
| MYHAS |
|
myosin heavy chain gene cluster antisense RNA
|
|
|
0.890 |
0.269 |
| HHIP-AS1 |
|
HHIP antisense RNA 1
|
|
|
1.000 |
0.077 |
| LINC01811 |
|
long intergenic non-protein coding RNA 1811
|
|
|
0.890 |
0.192 |
| GULOP |
|
gulonolactone (L-) oxidase, pseudogene
|
|
|
0.805 |
0.308 |
| LINC01440 |
|
long intergenic non-protein coding RNA 1440
|
|
|
1.000 |
0.038 |
| CT70 |
|
cancer/testis associated transcript 70
|
|
|
1.000 |
0.038 |
| CYP2F2P |
|
cytochrome P450 family 2 subfamily F member 2, pseudogene
|
|
|
|
|
| TEX26-AS1 |
|
TEX26 antisense RNA 1
|
|
|
1.000 |
0.077 |
| NPAS2-AS1 |
|
NPAS2 antisense RNA 1
|
|
|
1.000 |
0.038 |